Malignant brain tumors, a heterogeneous group of primary and metastatic neoplasms in the
central nervous system (CNS), are notorious for their highly invasive and devastating …

Brain cancer, especially the most common type of glioblastoma, is highly invasive and
known as one of the most devastating and deadly neoplasms. Despite surgical and medical …

Phototheranostic nanoagents are promising for early diagnosis and precision therapy of
cancer. However, their imaging ability and therapeutic efficacy are often limited due to the …

Serum protein as naturally essential biomacromolecules has recently emerged as a
versatile carrier for diagnostic and therapeutic drug delivery for cancer nanomedicine with …

Phototherapies including photothermal therapy (PTT) and photodynamic therapy (PDT)
have gained considerable attention due to their high tumor ablation efficiency, excellent …

Glioblastoma multiforme is one of the most fatal intracranial tumors with no effective
treatment. The drug concentration in tumor sites is usually insufficient to reach therapeutic …

Advances in phototheranostics revolutionized glioma intraoperative fluorescence imaging
and phototherapy. However, the lack of desired active targeting agents for crossing the …

The greatest obstacle to using drugs to treat brain tumors is the blood‐brain barrier (BBB),
making it difficult for conventional drug molecules to enter the brain. Therefore, how to safely …

Proteins, a type of natural biopolymer that possess many prominent merits, have been
widely utilized to engineer nanomedicine for fighting against cancer. Motivated by their ever …

Indocyanine green (ICG) is a water-soluble dye that was approved by the FDA for
biomedical purposes in 1956. Initially used to measure cardiocirculatory and hepatic …